You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proliferative diabetic retinopathy

Showing 1 - 25 of 8,232
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-proliferative Diabetic Retinopathy Trial (OTX-TKI, Sham)

Not yet recruiting
  • Non-proliferative Diabetic Retinopathy
  • (no location specified)
Jan 12, 2023

Proliferative Diabetic Retinopathy, Vitrectomy Trial in Tianjin (beveled 27G+ vitrectomy system, standard 25G+ vitrectomy

Completed
  • Proliferative Diabetic Retinopathy
  • Vitrectomy
  • beveled 27G+ vitrectomy system
  • standard 25G+ vitrectomy system
  • Tianjin, China
    Tianjin Medical University Eye Hospital
Jan 30, 2023

OCT and OCT-A Afer Diabetic Vitrectomy in PDR

Not yet recruiting
  • Proliferative Diabetic Retinopathy
  • OCT and OCT-A
  • (no location specified)
Jul 4, 2023

Dyslipidemia and Diabetic Retinopathy

Recruiting
  • Diabetic Retinopathy
  • Dyslipidemia
  • 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
  • Healthy Controls 15 age matched control subjects
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2022

Risk Prediction Model for Long-term Low Vision After Vitrectomy

Recruiting
  • Proliferative Diabetic Retinopathy
  • +2 more
    • Tianjin, Tianjin, China
      Tianjin medical university eye hosipital
    Nov 28, 2022

    Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)

    Completed
    • Proliferative Diabetic Retinopathy
    • preoperative intravitreal injections of ranibizumab or conbercept
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 7, 2022

    Specular Microscopy in Proliferative Diabetic Retinopathy

    Not yet recruiting
    • Corneal Endothelial Cell Changes in Diabetic Patients
    • Specular microscopy
    • (no location specified)
    Apr 28, 2023

    Proliferative Diabetic Retinopathy, Vitreous Hemorrhage, Tractional Retinal Detachment Trial in Monastir (Bevacizumab Injection

    Recruiting
    • Proliferative Diabetic Retinopathy
    • +2 more
    • Bevacizumab Injection [Avastin]
    • Peripheral Retinal Cryoapplication
    • Monastir, Tunisia
      Fattouma Bourguiba University Hospital - Ophthalmology Departmen
    Aug 22, 2022

    Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)

    Not yet recruiting
    • Non Proliferative Diabetic Retinopathy(NPDR)
    • pars plana vitrectomy(PPV)
    • +2 more
    • Tianjin, China
      Tianjin medical university eye hospital
    May 10, 2023

    Non Proliferative Diabetic Retinopathy Trial in Seoul (Entelon Tab. 50mg, Placebo)

    Recruiting
    • Non Proliferative Diabetic Retinopathy
    • Entelon Tab. 50mg
    • Placebo
    • Seoul, Korea, Republic of
      Hallym University Kangnam Sacred Heart Hospital
    Jul 19, 2022

    Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

    Recruiting
    • Mild Non-proliferative Diabetic Retinopathy
    • +2 more
    • Ranibizumab Injection [Lucentis]
    • Phacoemulsification
    • Shanghai, Shanghai, China
      Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
    May 18, 2022

    Prophylactic PRP in Moderate NPDR

    Completed
    • Eye Diseases
    • +2 more
    • PRP
    • Assiut, Egypt
      Assiut University
    Sep 14, 2022

    Eyes With Non Proliferative Diabetic Retinopathy in Diabetes

    Recruiting
    • NPDR - Non Proliferative Diabetic Retinopathy
    • +2 more
    • Biomarkers
    • Dijon, France
    • +4 more
    Jul 18, 2022

    Diabetic Retinopathy Trial (slow-release dexamethasone implant)

    Not yet recruiting
    • Diabetic Retinopathy
    • slow-release dexamethasone implant
    • (no location specified)
    Jun 8, 2022

    Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)

    Completed
    • Proliferative Diabetic Retinopathy
    • preoperative group and intraoperative group
    • Beijing, Beijing, China
      People's Hospital of Peking University
    Jun 1, 2022

    Proliferative Diabetic Retinopathy Trial in Beijing (IVA injection before vitrectomy)

    Completed
    • Proliferative Diabetic Retinopathy
    • IVA injection before vitrectomy
    • Beijing, Beijing, China
      People's Hospital of Peking University
    Jul 26, 2022

    Diabetic Retinopathy Visually Threatening Trial in Montemorelos (ILM Peeling, No ILM Peeling)

    Active, not recruiting
    • Diabetic Retinopathy Visually Threatening
    • ILM Peeling
    • No ILM Peeling
    • Montemorelos, Nuevo Leon, Mexico
      Hospital La Carlota
    Nov 20, 2021

    Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)

    Recruiting
    • Non-proliferative Diabetic Retinopathy
    • OPL-0401 Dose 1
    • +2 more
    • Mountain View, California
    • +20 more
    Dec 16, 2022

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Proliferative Diabetic Retinopathy Trial in Beijing (proactive Anti-VEGF (conbercept) use, passive Anti-VEGF (conbercept) use)

    Recruiting
    • Proliferative Diabetic Retinopathy
    • proactive Anti-VEGF (conbercept) use
    • passive Anti-VEGF (conbercept) use
    • Beijing, Beijing, China
      Peking University Third Hospital
    Dec 13, 2022

    Neovascular Glaucoma, Proliferative Diabetic Retinopathy Trial (anti-VEGF)

    Not yet recruiting
    • Neovascular Glaucoma
    • Proliferative Diabetic Retinopathy
    • (no location specified)
    Dec 13, 2021

    Type2 Diabetes, Diabetic Retinopathy Trial in China (Tangningtongluo tablets, Calcium dobesilate capsules)

    Recruiting
    • Type2 Diabetes
    • Diabetic Retinopathy
    • Tangningtongluo tablets
    • Calcium dobesilate capsules
    • Chongqing, Chongqing, China
    • +9 more
    Jun 27, 2022

    Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

    Not yet recruiting
    • Macular Degeneration, Age Related
    • +4 more
    • VISUPRIME
    • Placebo
    • Perugia, PG, Italy
      Ospedale Santa Maria della Misericordia
    Dec 22, 2022

    Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)

    Not yet recruiting
    • Non-Proliferative Diabetic Retinopathy
    • Bakersfield, California
    • +18 more
    Jan 25, 2023

    Diabetic Retinopathy, Oxidative Stress, Diabetes Trial in Guadalajara (Combined antioxidant therapy, Placebo)

    Completed
    • Diabetic Retinopathy
    • +2 more
    • Combined antioxidant therapy
    • Placebo
    • Guadalajara, Jalisco, Mexico
      Institute of Experimental and Clinical Therapeutics,
    Mar 21, 2022